Agilent Technologies, Inc.
Close on Nov 20, 2026Market cap $48.04BP/E 33.6Yield 0.58%
Agilent Technologies FDA MAUDE Adverse Event Reports by Quarter
FDA MAUDE Adverse Event Reports — Agilent Technologies & Dako Total (reports)
Agilent Technologies FDA MAUDE Adverse Event Reports: 3 in Q3 FY26, down 70.0% from a year earlier.
Where the Q3 FY26 figure comes from
Source: U.S. FDA MAUDE Adverse Event Reports Database (openFDA API — Agilent Technologies & Dako Total) ↗
Reported in U.S. Food & Drug Administration (openFDA API).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up FDA MAUDE Adverse Event Reports
- FDA MAUDE Device Malfunction Reports — Agilent Technologies & Dako (reports)2 · Q3 FY26
- FDA MAUDE Injury Reports — Agilent Technologies & Dako (reports)1 · Q3 FY26
- FDA MAUDE Death Reports — Agilent Technologies & Dako (reports)0 · Q3 FY26
- FDA Medical Device Recalls — Agilent Technologies & Dako (recalls)0 · Q3 FY26
- FDA Device Enforcement Actions — Agilent Technologies & Dako (actions)0 · Q3 FY26
- FDA MAUDE Adverse Event Reports — U.S. Medical Device Industry Total (reports)963,661 · Q3 FY26
Cite this data
StockData. (2026). Agilent Technologies FDA MAUDE Adverse Event Reports, quarterly Q1 FY16–Q3 FY26 [Data set]. Compiled from Agilent Technologies SEC filings and investor materials. https://stockdatahq.com/stocks/a/kpis/fda-maude-total
See every metric in the Agilent Technologies KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?